{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:12:58Z","timestamp":1778861578344,"version":"3.51.4"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This supplement presents scientific reports from industry-sponsored IDWeek 2025 symposia, highlighting selected advances in infectious diseases and HIV care through clinical case scenarios. One article explores therapeutic approaches to metabolic complications in people with HIV, emphasizing treatment strategies and the clinical reasoning that supports individualized management of excess adiposity. The second examines the clinical integration of metagenomic next-generation sequencing for diagnosing central nervous system infections, outlining both its opportunities and limitations within current diagnostic pathways.<\/jats:p>","DOI":"10.1093\/cid\/ciag206","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T11:35:25Z","timestamp":1775561725000},"page":"S85-S86","source":"Crossref","is-referenced-by-count":0,"title":["Selected Industry Highlights From IDWeek 2025"],"prefix":"10.1093","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4774-5590","authenticated-orcid":false,"given":"Jean-Jacques","family":"Parienti","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Caen University Hospital , Caen ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shangxin (Shaun)","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, UCLA David Geffen School of Medicine , Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Grinspoon","sequence":"additional","affiliation":[{"name":"Metabolism Unit, Massachusetts General Hospital and Nutrition Obesity Research Center, Harvard Medical School , Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"2026051511401366400_ciag206-B1","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1056\/NEJM199210153271606","article-title":"The publication of sponsored symposiums in medical journals","volume":"327","author":"Bero","year":"1992","journal-title":"N Engl J Med"},{"key":"2026051511401366400_ciag206-B2","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1093\/cid\/ciag121","article-title":"Differing presentations of excess Visceral Abdominal Fat (EVAF) in people living with hiv: two clinical cases highlighting distinct therapeutic pathways with tesamorelin and GLP-1 receptor agonists","volume":"82","author":"Beach","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026051511401366400_ciag206-B3","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1056\/NEJMoa072375","article-title":"Metabolic effects of a growth hormone-releasing factor in patients with HIV","volume":"357","author":"Falutz","year":"2007","journal-title":"N Engl J Med"},{"key":"2026051511401366400_ciag206-B4","doi-asserted-by":"crossref","first-page":"e821","DOI":"10.1016\/S2352-3018(19)30338-8","article-title":"Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial","volume":"6","author":"Stanley","year":"2019","journal-title":"Lancet HIV"},{"key":"2026051511401366400_ciag206-B5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026051511401366400_ciag206-B6","doi-asserted-by":"crossref","first-page":"e2537619","DOI":"10.1001\/jamanetworkopen.2025.37619","article-title":"Implications of a new obesity definition among the all of us cohort","volume":"8","author":"Fourman","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026051511401366400_ciag206-B7","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1093\/cid\/ciag120","article-title":"Metagenomic next-generation sequencing in CNS Infections: clinical strategies, evidence, and best practices","volume":"82","author":"Waldrop","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026051511401366400_ciag206-B8","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa1803396","article-title":"Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis","volume":"380","author":"Wilson","year":"2019","journal-title":"N Engl J Med"},{"key":"2026051511401366400_ciag206-B9","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s40291-024-00727-9","article-title":"Clinical metagenomic next-generation sequencing for diagnosis of central nervous system infections: advances and challenges","volume":"28","author":"Su","year":"2024","journal-title":"Mol Diagn Ther"},{"key":"2026051511401366400_ciag206-B10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/ice.2024.242","article-title":"Real-world clinical impact of plasma cell-free DNA metagenomic next-generation sequencing assay","volume":"46","author":"Kaur","year":"2025","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2026051511401366400_ciag206-B11","doi-asserted-by":"crossref","first-page":"948","DOI":"10.3201\/eid3105.241657","article-title":"Metagenomic identification of Fusarium solani strain as cause of US fungal meningitis outbreak associated with surgical procedures in Mexico, 2023","volume":"31","author":"Chiu","year":"2025","journal-title":"Emerg Infect Dis"},{"key":"2026051511401366400_ciag206-B12","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaf390","article-title":"Metagenomic next-generation sequencing of cerebrospinal fluid: first year experience at a Tertiary Referral Hospital [manuscript published online ahead of print 16 July 2025]","author":"Alvarez Mulett","year":"2025","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/Supplement_4\/S85\/68293158\/ciag206.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/Supplement_4\/S85\/68293158\/ciag206.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:40:17Z","timestamp":1778859617000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/82\/Supplement_4\/S85\/8678929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":12,"journal-issue":{"issue":"Supplement_4","published-online":{"date-parts":[[2026,5,15]]},"published-print":{"date-parts":[[2026,5,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciag206","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5,15]]},"published":{"date-parts":[[2026,5,15]]}}}